0000899243-21-003420.txt : 20210126 0000899243-21-003420.hdr.sgml : 20210126 20210126213325 ACCESSION NUMBER: 0000899243-21-003420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210122 FILED AS OF DATE: 20210126 DATE AS OF CHANGE: 20210126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELANOFF JOSEPH K CENTRAL INDEX KEY: 0001286199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 21556541 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-22 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001286199 BELANOFF JOSEPH K C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 1 1 0 0 Chief Executive Officer Common Stock 2021-01-22 4 M 0 800000 4.42 A 3299214 D Common Stock 2021-01-22 4 F 0 481088 28.06 D 2818126 D Stock Option (Right to Buy) 4.42 2021-01-22 4 M 0 800000 0.00 D 2021-05-19 Common Stock 800000 0 D These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on January 22, 2021. The options subject to the net exercise were to expire on May 19, 2021. Fully exercisable. /s/ G. Charles Robb, Attorney-in-Fact for Joseph K. Belanoff 2021-01-26